Central Nervous System Mesenchymal, Non-Meningothelial Neoplasm

Central Nervous System Mesenchymal, Non-Meningothelial Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

12 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03641326	Sunitinib in Sarcomas of the Central Nervous System	terminated	Phase 2	5	National Cancer Institute (NCI)NIH	1	Apr 19, 2022	clinicaltrials
NCT01234805	Yoga Therapy in Treating Patients With Malignant Brain Tumors	terminated	N/A	9	Wake Forest University Health SciencesOTHER	1	Jul 3, 2018	clinicaltrials
NCT02967380	Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases	terminated	N/A	14	University of Southern CaliforniaOTHER	1	Mar 27, 2017	clinicaltrials
NCT00110032	Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain Tumors

Data updated 23 days agoSource updated Apr 19, 2022source: clinicaltrials